AstraZeneca delivers life-changing health access initiatives across African Continent in 2020
Pushing the boundaries of science to deliver life-changing medicines
JOHANNESBURG, South Africa, December 21, 2020/APO Group/
The World Health Organisation (WHO) identifies Non-Communicable Diseases (NCDs) as the number one cause of death worldwide [1], disproportionately affecting people in low and middle income countries [2]. Similarly, the World Economic Forum (WEF) has predicted that NCDs will cost the worldwide economy more than $47 trillion in lost productivity and wages by 2030 [3].
Through public and private partnerships (PPP’s), these challenges have started to be addressed to ensure that an equitable and inclusive healthcare system is available in the future to respond to the healthcare needs of all Africans.
The World Health Organisation (WHO) identifies Non-Communicable Diseases (NCDs) as the number one cause of death worldwide [1], disproportionately affecting people in low and middle income countries [2]. Similarly, the World Economic Forum (WEF) has predicted that NCDs will cost the worldwide economy more than $47 trillion in lost productivity and wages by 2030 [3].
Through public and private partnerships (PPP’s), these challenges have started to be addressed to ensure that an equitable and inclusive healthcare system is available in the future to respond to the healthcare needs of all Africans.
Barbara Nel, AstraZeneca’s Country President for African Cluster (South Africa, Sub Sahara and French Speaking Africa) said “At AstraZeneca we recognise that breakthrough science and healthcare doesn’t happen in isolation, it is the result of collaboration and partnership. Our commitment to our patients and our responsibility to work closely with partners and stakeholders is in
The World Health Organisation (WHO) identifies Non-Communicable Diseases (NCDs) as the number one cause of death worldwide [1], disproportionately affecting people in low and middle income countries [2]. Similarly, the World Economic Forum (WEF) has predicted that NCDs will cost the worldwide economy more than $47 trillion in lost productivity and wages by 2030 [3].
Through public and private partnerships (PPP’s), these challenges have started to be addressed to ensure that an equitable and inclusive healthcare system is available in the future to respond to the healthcare needs of all Africans.
Barbara Nel, AstraZeneca’s Country President for African Cluster (South Africa, Sub Sahara and French Speaking Africa) said “At AstraZeneca we recognise that breakthrough science and healthcare doesn’t happen in isolation, it is the result of collaboration and partnership. Our commitment to our patients and our responsibility to work closely with partners and stakeholders is in
Fêtes : coups de cœur d Afrique à offrir lepoint.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lepoint.fr Daily Mail and Mail on Sunday newspapers.